Cargando…

Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka

PURPOSE: As experienced by many countries, Sri Lanka is currently experiencing a large COVID-19 outbreak, with over 90 cases/one million population. The previous outbreak, which was due to the B.1.411 virus (Sri Lankan lineage) resulted in a significantly fewer number of cases and deaths compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranasinghe, D., Jeewandara, C., Jayathilaka, D., Ariyarathne, D., Jayadas, T., Madushanka, D., Gomes, L., Ogg, G., Parker, M., De Silva, T., Malavige, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884804/
http://dx.doi.org/10.1016/j.ijid.2021.12.058
_version_ 1784660246888710144
author Ranasinghe, D.
Jeewandara, C.
Jayathilaka, D.
Ariyarathne, D.
Jayadas, T.
Madushanka, D.
Gomes, L.
Ogg, G.
Parker, M.
De Silva, T.
Malavige, N.
author_facet Ranasinghe, D.
Jeewandara, C.
Jayathilaka, D.
Ariyarathne, D.
Jayadas, T.
Madushanka, D.
Gomes, L.
Ogg, G.
Parker, M.
De Silva, T.
Malavige, N.
author_sort Ranasinghe, D.
collection PubMed
description PURPOSE: As experienced by many countries, Sri Lanka is currently experiencing a large COVID-19 outbreak, with over 90 cases/one million population. The previous outbreak, which was due to the B.1.411 virus (Sri Lankan lineage) resulted in a significantly fewer number of cases and deaths compared to the current outbreak caused by B.1.1.7. Therefore, we sought to explore if the differences in the transmission rates and higher mortality rates with the introduction of B.1.1.7 is due to an increased expression of sub-genomic RNA, which is an essential step in the virus life cycle. METHODS & MATERIALS: Sputum or nasopharyngeal samples of 472 patients with SARS-CoV-2 infection were included in the analysis. Samples with the cycle threshold <30, were sequenced using 247 amplicons targeting the SARS-CoV-2 genome (MN908947v3). Library preparation was done using AmpliSeq prep kit and sequenced either on illumina iSeq100 or Nextseq550 platforms. Basecalling and demultiplexing were done using the default bcl2fastq (v2.20) pipeline. Raw index-trimmed fastqs were analyzed for sub-genomic RNA using Periscope (https://github.com/sheffield-bioinformatics-core/periscope). Raw reads were aligned and checked for the leader sequence at the start of each open reading frame (ORF). The sgRNA detected reads were counted, classified into ORFs and normalized using the genomic RNA counts at each position. Groups were compared with an unpaired Wilcoxon test using R\rstatix package. Figures were generated in R\ggpubr. RESULTS: Out of the remaining 434 datasets after the quality control step, 164 were of B.1.1.7 lineage while 237 were B.1.4.11. Means of the normalized sgRNA counts between B.1.411 and B.1.1.7 viruses were significantly different in six ORFs. Viruses of the B.1.411 lineage expressed significantly higher sgRNA for Spike protein (p = 0.014), ORF3a (p = 0. 0001), Membrane protein (p = 3.62E-10), ORF8 (p = 1.81E-05), and ORF7a (p = 0.0004) than those in B.1.1.7 samples. Contrastingly, Nucleocapsid (N) protein had significantly higher sgRNA expression in B.1.1.7 samples (p=0.0001). CONCLUSION: Our results suggest that increased expression of sgRNA for a particular virus lineage does not necessarily associate with higher transmissibility as higher expression of sgRNA of B.1.1.7 compared to the B.1.411 lineage virus was only seen for the N protein.
format Online
Article
Text
id pubmed-8884804
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88848042022-03-01 Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka Ranasinghe, D. Jeewandara, C. Jayathilaka, D. Ariyarathne, D. Jayadas, T. Madushanka, D. Gomes, L. Ogg, G. Parker, M. De Silva, T. Malavige, N. Int J Infect Dis Ps04.01 (491) PURPOSE: As experienced by many countries, Sri Lanka is currently experiencing a large COVID-19 outbreak, with over 90 cases/one million population. The previous outbreak, which was due to the B.1.411 virus (Sri Lankan lineage) resulted in a significantly fewer number of cases and deaths compared to the current outbreak caused by B.1.1.7. Therefore, we sought to explore if the differences in the transmission rates and higher mortality rates with the introduction of B.1.1.7 is due to an increased expression of sub-genomic RNA, which is an essential step in the virus life cycle. METHODS & MATERIALS: Sputum or nasopharyngeal samples of 472 patients with SARS-CoV-2 infection were included in the analysis. Samples with the cycle threshold <30, were sequenced using 247 amplicons targeting the SARS-CoV-2 genome (MN908947v3). Library preparation was done using AmpliSeq prep kit and sequenced either on illumina iSeq100 or Nextseq550 platforms. Basecalling and demultiplexing were done using the default bcl2fastq (v2.20) pipeline. Raw index-trimmed fastqs were analyzed for sub-genomic RNA using Periscope (https://github.com/sheffield-bioinformatics-core/periscope). Raw reads were aligned and checked for the leader sequence at the start of each open reading frame (ORF). The sgRNA detected reads were counted, classified into ORFs and normalized using the genomic RNA counts at each position. Groups were compared with an unpaired Wilcoxon test using R\rstatix package. Figures were generated in R\ggpubr. RESULTS: Out of the remaining 434 datasets after the quality control step, 164 were of B.1.1.7 lineage while 237 were B.1.4.11. Means of the normalized sgRNA counts between B.1.411 and B.1.1.7 viruses were significantly different in six ORFs. Viruses of the B.1.411 lineage expressed significantly higher sgRNA for Spike protein (p = 0.014), ORF3a (p = 0. 0001), Membrane protein (p = 3.62E-10), ORF8 (p = 1.81E-05), and ORF7a (p = 0.0004) than those in B.1.1.7 samples. Contrastingly, Nucleocapsid (N) protein had significantly higher sgRNA expression in B.1.1.7 samples (p=0.0001). CONCLUSION: Our results suggest that increased expression of sgRNA for a particular virus lineage does not necessarily associate with higher transmissibility as higher expression of sgRNA of B.1.1.7 compared to the B.1.411 lineage virus was only seen for the N protein. Published by Elsevier Ltd. 2022-03 2022-02-28 /pmc/articles/PMC8884804/ http://dx.doi.org/10.1016/j.ijid.2021.12.058 Text en Copyright © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Ps04.01 (491)
Ranasinghe, D.
Jeewandara, C.
Jayathilaka, D.
Ariyarathne, D.
Jayadas, T.
Madushanka, D.
Gomes, L.
Ogg, G.
Parker, M.
De Silva, T.
Malavige, N.
Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title_full Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title_fullStr Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title_full_unstemmed Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title_short Sub-genomic RNA Expression in SARS-CoV-2 B.1.411 and B.1.1.7 Infections in Sri Lanka
title_sort sub-genomic rna expression in sars-cov-2 b.1.411 and b.1.1.7 infections in sri lanka
topic Ps04.01 (491)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884804/
http://dx.doi.org/10.1016/j.ijid.2021.12.058
work_keys_str_mv AT ranasinghed subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT jeewandarac subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT jayathilakad subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT ariyarathned subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT jayadast subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT madushankad subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT gomesl subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT oggg subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT parkerm subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT desilvat subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka
AT malavigen subgenomicrnaexpressioninsarscov2b1411andb117infectionsinsrilanka